Spermidine decreases Na+,K+-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats  by Carvalho, Fabiano B. et al.
European Journal of Pharmacology 684 (2012) 79–86
Contents lists available at SciVerse ScienceDirect
European Journal of Pharmacology
j ourna l homepage: www.e lsev ie r .com/ locate /e jpharNeuropharmacology and Analgesia
Spermidine decreases Na+,K+-ATPase activity through NMDA receptor and protein
kinase G activation in the hippocampus of rats
Fabiano B. Carvalho a, Carlos F. Mello b, Patricia C. Marisco b, Raquel Tonello a, Bruna A. Girardi a,
Juliano Ferreira a, Mauro S. Oliveira b, Maribel A. Rubin a,⁎
a Department of Chemistry, Center of Exact and Natural Sciences, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil
b Department of Physiology and Pharmacology, Center of Health Sciences, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil⁎ Corresponding author. Tel./fax: +55 55 3220 8053.
E-mail address: maribel.rubin@gmail.com (M.A. Rub
0014-2999 © 2012 Elsevier B.V.
doi:10.1016/j.ejphar.2012.03.046
Open access under the Elsa b s t r a c ta r t i c l e i n f oArticle history:
Received 24 October 2011
Received in revised form 19 March 2012
Accepted 23 March 2012
Available online 3 April 2012
Keywords:
Na+,K+-ATPase
Spermidine
NMDA receptor
Nitric oxide
PKG
HippocampusSpermidine is an endogenous polyamine with a polycationic structure present in the central nervous system of
mammals. Spermidine regulates biological processes, such as Ca2+ inﬂuxby glutamatergicN-methyl-D-aspartate
receptor (NMDA receptor), which has been associatedwith nitric oxide synthase (NOS) and cGMP/PKG pathway
activation and a decrease of Na+,K+-ATPase activity in rats' cerebral cortex synaptosomes. Na+,K+-ATPase
establishes Na+ and K+ gradients across membranes of excitable cells and by this means maintains membrane
potential and controls intracellular pH and volume. However, it has not been deﬁned whether spermidine
modulates Na+,K+-ATPase activity in the hippocampus. In this studywe investigatedwhether spermidine alters
Na+,K+-ATPase activity in slices of hippocampus from rats, and possible underlying mechanisms. Hippocampal
slices and homogenates were incubated with spermidine (0.05–10 μM) for 30 min. Spermidine (0.5 and 1 μM)
decreased Na+,K+-ATPase activity in slices, but not in homogenates. MK-801 (100 and 10 μM), a non-
competitive antagonist of NMDA receptor, arcaine (0.5 μM), an antagonist of the polyamine binding site at the
NMDA receptor, and L-NAME (100 μM), a NOS inhibitor, prevented the inhibitory effect of spermidine (0.5 μM).
ODQ (10 μM), a guanylate cyclase inhibitor, and KT5823 (2 μM), a protein kinase G inhibitor, also prevented the
inhibitory effect of spermidine on Na+,K+-ATPase activity. Spermidine (0.5 and 1.0 μM) increased NO2 plus NO3
(NOx) levels in slices, and MK-801 (100 μM) and arcaine (0.5 μM) prevented the effect of spermidine (0.5 μM)
on theNOx content. These results suggest that spermidine-induced decrease of Na+,K+-ATPase activity involves
NMDA receptor/NOS/cGMP/PKG pathway.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Spermidine is an aliphatic polyamine, which is present at high
concentrations in the brain (Carter, 1994), particularly in the hippocam-
pus (Anderson et al., 1975; Liu et al., 2008; Seiler and Schmidt-
Glenewinkel, 1975). Spermidine interacts with anionic domains of
macromolecules, modulating ion channel activity (Johnson, 1996),
including those of glutamatergic α-amino-3-hydroxy-5-methyl-4-
isoxazole propionate (AMPA) (Pellegrini-Giampietro, 2003) and N-
methyl-D-aspartate (NMDA) receptors (Anderson et al., 1975; Carter,
1994; Janne et al., 2005; Reynolds and Rothermund, 1995; Williams,
1997a,b).
Accumulating body of evidence suggests that polyamines dually
modulate the NMDA receptor (Rock and Macdonald, 1995; Williams,
1997b; Williams et al., 1994). Polyamines enhance [3H]MK-801 and
[3H]TCP binding to the NMDA receptor at low micromolar concen-
trations but, at high concentrations, do not alter the binding of thesein).
evier OA license.ligands (Ransom and Stec, 1988; Sacaan and Johnson, 1990b;Williams,
1997a,b). Accordingly, while low concentrations of polyamines
enhance NMDA-evoked currents, high concentrations produce less
enhancement or inhibit such currents (Rock and Macdonald, 1995;
Sprosen and Woodruff, 1990; Williams, 1997b).
NMDA receptor activation causes Ca2+ inﬂux and nitric oxide
synthase (NOS) activation with consequent nitric oxide (NO) produc-
tion (Prast and Philippu, 2001). NO stimulates guanylate cyclase,
increasing intracellular cyclic GMP (cGMP) levels (Garthwaite and
Balazs, 1978; Rubin and Ferrendelli, 1977), which activates cGMP-
dependent protein kinase (PKG). PKG-mediated effects on neurotrans-
mission include inhibition of Ca2+ currents (Meriney et al., 1994),
increase of ﬁring rate and neurotransmitter release (Akamatsu et al.,
1993; Branisteanu et al., 1988; Woody et al., 1986). PKG has been
implicated in long term potentiation (Anderson et al., 1975; Arancio
et al., 1995; Zhuo et al., 1994) and in Na+,K+-ATPase activity
regulation (Munhoz et al., 2003; Munhoz et al., 2005; Pontiggia et al.,
1998).
Na+,K+-ATPase (EC 3.6.3.9) plays a key role in the maintenance of
intracellular electrolyte homeostasis (Skou and Esmann, 1992), and
decreased enzyme activity or expression directly impairs signaling,
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Moseley et al., 2007). The Na+,K+-ATPase inhibitor ouabain increases
calcium inﬂux in brain slices (Fujisawa et al., 1965), induces
glutamate release in the spinal cord (Li and Stys, 2001) and causes
hippocampal cell death in rats (Lees et al., 1990). In addition,
glutamate decreases Na+,K+-ATPase activity synaptosomal fractions,
an effect that is prevented by L-NAME (Avrova et al., 1999).
Moreover, it has been reported that, while PKG increases Na+,K+-
ATPase activity in Xenopus oocytes (Fotis et al., 1999), proximal
trachea, striatum and cerebellum slices of rats (Munhoz et al., 2005,
Scavone et al., 2000; 2005), it decreases enzyme activity in brain
endothelial cells (Pontiggia et al., 1998), cornea, iris, lens and choroid
plexus of bovine (Ellis et al., 2000, 2001).
Accumulating evidence suggests that NO and spermidine signaling
pathways converge to cGMP/PKG pathway activation. However, until
the present moment, no study has addressed whether spermidine
modulates Na+,K+-ATPase activity. Therefore, the aim of this studywas
to investigate whether spermidine alters Na+,K+-ATPase activity, and
determine whether NMDA receptor/NOS/cGMP/PKG pathway is in-
volved in such an effect.
2. Material and methods
2.1. Animals
MaleWistar rats (250–300 g), housed in plastic cages (ﬁve per cage)
and maintained on a 12 h light/dark cycle (lights on at 07:00 AM), in a
temperature and humidity controlled environment were used. Food
andwater were available ad libitum (Guabi, SantaMaria, Rio Grande do
Sul, Brazil). All animal experimentation reported in this study was
conducted in accordance with Brazilian law no. 11.794/2008, which is
in agreement with the Policies on the Use of Animals and Humans in
Neuroscience Research, revised and approved by the Society for
Neuroscience Research in January 1995 and with the Institutional and
National regulations for animal research (process 068/2011). All efforts
were made to reduce the number of animals used, as well as minimize
their suffering.
2.2. Reagents
MK-801 (dizocilpine), N-[3-aminopropyl]-1.4-butanediamine tri-
hydrochloride (spermidine); Nω-nitro-L-arginine methyl ester (L-
NAME); 1H-[1,2,4]oxadiazolo[4,3-alpha] quinoxalin-1-one (ODQ);
2,3,9,10,11,12-hexahydro-10R-methoxy-2,9-dimethyl-1-oxo-9S,12R-
epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzo-diazocine-
10carboxylic acid methyl ester (KT5823) were obtained from Sigma (St.
Louis, MO, USA). The 1,4-diguanidinobutane sulfate (arcaine) was
obtained from Pfaltz & Bauer (Waterbury, CT, USA). KT5823 and arcaine
were dissolved in 100% dimethyl sulfoxide and then dilutedwith artiﬁcial
cerebrospinal ﬂuid, in such a way that dimethyl sulfoxide concentration
did not exceed 0.05% in the incubated solution.
2.3. Preparation of slices
Animals were killed by decapitation and the hippocampus was
immediately dissected and used for the preparation of slices (400 μm
thick) with a McIlwain tissue chopper. Slices were suspended in a
pre-gassed (carbogen) artiﬁcial cerebrospinal ﬂuid containing (in
mM): 1.25 NaH2PO4; 22 NaH2CO3; 1.8 MgCl2; 129.0 NaCl; 1.8 CaCl2;
3.5 KCl; 10 D-glucose, and pH was adjusted to 7.4 with carbogen. The
viability of hippocampal slices was assessed after preparation by
measuring lactate dehydrogenase activity with a standard commer-
cial kit (Labtest, Porto Alegre, RS, Brazil). Hippocampal slices were
viable for 60 min after preparation, and all experiments were
performed in 30 or 60 min.The effect of spermidine (0.05–10 μM) and drugs on hippocampal
Na+,K+-ATPase activity was investigated by incubating 8–10 slices
for 30 or 60 min at 37 °C. After the incubation period, the medium
was discarded and the slices were rinsed and gently homogenized in
ice-cold 10 mM Tris–HCl buffer, pH 7.4, for determination of Na+,K+-
ATPase activity. Drug concentrations used in this study were
determined based on pilot experiments.
In those experiments designed to study the effect of spermidine on
Na+,K+-ATPase activity in homogenates, 8–10hippocampal sliceswere
homogenized and incubated with pre-gassed (carbogen) artiﬁcial
cerebrospinal ﬂuid containing spermidine (0.5–1 μM) for 30 min.
Then the homogenate was diluted in ice-cold 10 mM Tris–HCl buffer,
pH 7.4, for determination of Na+,K+-ATPase activity. To investigate
whether an intracellular component can block the inhibitory effect of
spermidine on the activity of Na+,K+-ATPase, 8–10 slices were
incubatedwith tissue homogenatewith pre-gassed (carbogen) artiﬁcial
cerebrospinal ﬂuid containing spermidine (0.5–1 μM) for 30 min.
Then the homogenate was discarded and the slices were washed and
homogenized in ice-cold 10 mM Tris–HCl buffer, pH 7.4, for
determination of Na+,K+-ATPase activity.2.4. Na+,K+-ATPase activity measurement
Na+,K+-ATPase activity was measured as previously described
(Wyse et al., 2000) with minor modiﬁcations. Brieﬂy, the assay
medium consisted of (in mM) 30 Tris–HCl buffer (pH 7.4), 0.1 EDTA,
50 NaCl, 5 KCl, 6 MgCl2 and 50 μg of protein in the presence or
absence of ouabain (1 mM), in a ﬁnal volume of 350 μl. The reaction
was started by the addition of adenosine triphosphate to a ﬁnal
concentration of 3 mM. After 30 min at 37 °C, the reaction was
stopped by the addition of 70 μl of 50% (w/v) trichloroacetic acid.
Saturating substrate concentrations were used, and reaction was
linear with protein and time. Appropriate controls were included in
the assays for non-enzymatic hydrolysis of ATP. The amount of
inorganic phosphate (Pi) released was quantiﬁed colorimetrically, as
previously described (Fiske and Subbarow, 1925), using NaH2PO4 as
reference standard. Speciﬁc Na+,K+-ATPase activity was calculated
by subtracting the ouabain-insensitive activity from the overall
activity (in the absence of ouabain) and expressed in nmol of Pi/mg
of protein/min.2.5. Assay of NOx (NO2 plus NO3) as a marker of NO synthesis
For NOx determination, an aliquot (200 μl) was homogenized in
200 mM Zn2SO4 and acetonitrile (96%, HPLC grade). After, the homoge-
natewas centrifuged at 16,000 ×g for 20 min at 4 °C and supernatantwas
separated for analysis of the NOx content as previously described
(Miranda et al., 2001). The resulting pellet was suspended in NaOH
(6 M) for protein determination.2.6. Protein determination
Protein content was determined colorimetrically (Bradford, 1976)
using bovine serum albumin (1 mg/ml) as standard.2.7. Statistical analyses
Data were analyzed by a one- or two-way ANOVA. Post hoc
analyses were carried out by the Student–Newman–Keuls (SNK) test.
A probability of Pb0.05 was considered signiﬁcant. All data are
expressed as mean±S.E.M.
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3.1. Spermidine decreases the Na+,K+-ATPase activity in hippocampal
slices
Fig. 1 shows the effect of a 30 min- (Fig. 1A) or a 60 min-
incubation (Fig. 1B) with spermidine (0.05–10 μM) and (0.5–1 μM)
respectively, on the activity of Na+,K+-ATPase in slices of hippocam-
pus. Statistical analysis (one-way ANOVA followed by SNK test)
revealed that 30 min- and 60 min-incubation with spermidine, at the
concentrations of 0.5 and 1 μM decreased Na+,K+-ATPase activity
when compared with respective controls [F (6,42)=13.290, Pb0.001,
Fig. 1A] and F [(2,12)=25.990, Pb0.001, Fig. 1B]. Fig. 1C shows the
results of the experiment designed to investigate whether spermidine
(0.5 and 1 μM) altered Na+,K+-ATPase activity by directly interacting
with the enzyme in hippocampal homogenates. In this experimental
condition spermidine did not decrease Na+,K+-ATPase activity
[F (2,12)=0.074, P>0.05, Fig. 1C] suggesting that spermidine-
induced decrease of Na+,K+-ATPase activity is not a direct effect on
the enzyme and requires intact cells. Fig. 1D shows the results of the
experiment designed to investigate whether an intracellular
component can block the inhibitory effect of spermidine (0.5 and
1 μM) on the activity of Na+,K+-ATPase. In this experimental condition
spermidine decreases Na+,K+-ATPase activity [F (2,12)=9.236,
Pb0.01, Fig. 1D], suggesting that the exposure of spermidine to
intracellular content by incubating the slices plus homogenate does
not prevent the inhibitory effect of spermidine (0.5 and 1 μM) on the
Na+,K+-ATPase activity in slices.
3.2. MK-801 and arcaine prevent the inhibitory effect of spermidine
Fig. 2A shows the effect of incubation of spermidine (0.5 μM) and
MK-801 (100 μM) onNa+,K+-ATPase activity of rat hippocampal slices.
Statistical analysis (two-way ANOVA) showed a signiﬁcant vehicle or
spermidine versus vehicle or MK-801 interaction [F (1,20)=11.410,Fig. 1. Effect of a 30 min (A) or a 60 min-incubation (B) with spermidine (0.05–10 μM) and
shown the effect of a 30 min-incubation with spermidine (0.5 and 1 μM) on Na+,K+-AT
homogenates (D). Data are mean±S.E.M for n=7 (A), n=5 (B), n=5 (C) and n=5 (D) iPb0.05, Fig. 2A], suggesting that co-incubation with a non-competitive
antagonist of the NMDA receptor prevents spermidine-induced de-
crease of Na+,K+-ATPase activity.
Fig. 2B shows the effect of incubation of spermidine (0.5 μM) and
MK-801 (10 μM) on Na+,K+-ATPase activity of rat hippocampal slices.
Statistical analysis (two-way ANOVA) showed a signiﬁcant vehicle or
spermidine versus vehicle or MK-801 interaction [F (1,22)=13.390,
Pb0.05, Fig. 2B]. As can be observed in Fig. 2B, a lower concentration of
MK-801 (10 μM) also prevented the inhibitory effect of spermidine on
Na+,K+-ATPase activity, corroborating our early results obtained with
100 μM MK-801. This result makes the possibility that the effect of
100 μMMK-801 occurs via non-selective mechanisms sound unlike.
Fig. 2C shows the effect of co-incubation of spermidine (0.5 μM) and
arcaine (0.5 μM) on Na+,K+-ATPase activity of rat hippocampal slices.
Statistical analysis (two-way ANOVA) showed a signiﬁcant vehicle or
spermidine versus vehicle or arcaine interaction [F (1,24)=4.540,
Pb0.05, Fig. 2C], suggesting that co-incubationwith an antagonist of the
polyamine-binding site at the NMDA receptor prevents spermidine-
induced decrease of Na+,K+-ATPase activity.
3.3. L-NAME prevents the inhibitory effect of spermidine
Fig. 3 shows the effect of the co-incubation of spermidine (0.5 μM)
and of L-NAME (100 μM), NOS inhibitor, on Na+,K+-ATPase activity in
hippocampal slices. Statistical analysis (two-way ANOVA) showed a
signiﬁcant vehicle or spermidine versus vehicle or L-NAME interaction
[F (1,20)=7.976, Pb0.05, Fig. 3], suggesting that co-incubation of
L-NAME prevents the decrease of Na+,K+-ATPase activity induced
by spermidine.
3.4. ODQ prevents the inhibitory effect of spermidine
Fig. 4 shows the effect of the co-incubation of spermidine (0.5 μM)
and ODQ (10 μM), a guanylate cyclase inhibitor, on Na+,K+-ATPase
activity in hippocampal slices. Statistical analysis (two-way ANOVA)(0.5–1 μM) respectively, on Na+,K+-ATPase activity of rat hippocampal slices. It is also
Pase activity of rat hippocampal homogenates (C) and rat hippocampal slices plus
n each group. *Indicates a signiﬁcant difference compared with the control group.
Fig. 2. Effect of co-incubation of spermidine (0.5 μM) and MK-801 (100 μM) (A),
spermidine (0.5 μM) and MK-801 (10 μM) (B) or spermidine (0.5 μM) and arcaine
(0.5 μM) (C) on Na+,K+-ATPase activity of rat hippocampal slices. Data are mean±S.E.M
for n=6 (A), n=6 (B) and n=7 (C) in each group. *Indicates a signiﬁcant difference
compared with control group.
Fig. 4. Effect of co-incubation of spermidine (0.5 μM) and 1H-[1,2,4]oxadiazolo[4,3-alpha]
quinoxalin-1-one (ODQ, 10 μM) on Na+,K+-ATPase activity of rat hippocampal slices.
Data are mean±S.E.M for n=8 in each group. *Indicates a signiﬁcant difference
compared with control group.
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interaction [F (1,28)=7.397, Pb0.05, Fig. 4], suggesting that the
incubation with ODQ prevents the decrease of Na+,K+-ATPase
activity induced by spermidine.Fig. 3. Effect of co-incubation of spermidine (0.5 μM) and L-NAME (100 μM) on Na+,
K+-ATPase activity of rat hippocampal slices. Data are mean±S.E.M for n=6 in each
group. *Indicates a signiﬁcant difference compared with control group.3.5. KT5823, PKG inhibitor, prevents the inhibitory effect of spermidine
Fig. 5 shows the effect of the co-incubation of spermidine (0.5 μM)
and KT-5823 (2 μM), a cGMP-dependent protein kinase selective
inhibitor, on Na+,K+-ATPase activity of hippocampal slices. Statistical
analysis (two-way ANOVA) showed also a signiﬁcant vehicle or
spermidine versus vehicle or KT-5823 interaction [F (1,24)=9.385,
Pb0.05, Fig. 5], suggesting that the incubationwithKT-5823 also prevents
the decrease of Na+,K+-ATPase activity induced by spermidine.
3.6. Spermidine increases the NOx content in slices of hippocampus
Fig. 6 shows the effect of a 30 min incubation with spermidine (0.5
and 1.0 μM) on the NOx content in slices of hippocampus. Statistical
analysis (one-way ANOVA followed by SNK test) revealed that
30 min-incubation with spermidine, at the concentrations of 0.5 and
1 μM increased NOx content when compared with respective control
[F (2,20)=17.16, Pb0.001, Fig. 6].
3.7. MK-801 and arcaine prevent the increasing the NOx content induced
by spermidine
Fig. 7A shows the effect of incubation of spermidine (0.5 μM) and
MK-801 (100 μM) on NOx content in slices of hippocampus. Statistical
analysis (two-way ANOVA) showed a signiﬁcant vehicle or spermidine
versus vehicle orMK-801 interaction [F (1,22)=6.720, Pb0.05, Fig. 7A],
suggesting that co-incubation with a non-competitive antagonist of the
NMDA receptor prevents spermidine-induced increase of NOx levels.
Fig. 7B shows the effect of co-incubation of spermidine (0.5 μM) and
arcaine (0.5 μM) on NOx content of rat hippocampal slices. Statistical
analysis (two-way ANOVA) showed a signiﬁcant vehicle or spermidineFig. 5. Effect of co-incubation of spermidine (0.5 μM) and KT-5823 (2 μM) on Na+,K+-
ATPase activity of rat hippocampal slices. Data are mean±S.E.M for n=7 in each
group. *Indicates a signiﬁcant difference compared with control group.
Fig. 6. Effect of a 30 min incubation with spermidine (0.5–1 μM) on NOx content of rat
hippocampal slices. Data are mean±S.E.M for n=10 in each group. *Indicates a
signiﬁcant difference compared with control group.
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suggesting that co-incubation with an antagonist of the polyamine-
binding site at the NMDA receptor prevents spermidine-induced
increase of NOx levels.4. Discussion
In this study we showed that spermidine decreases Na+,K+-ATPase
activity in hippocampal slices of rats. We also showed that MK-801,
arcaine, L-NAME, ODQ and KT5823 prevented the inhibitory effect of
spermidine on Na+,K+-ATPase activity. Interestingly, spermidine did
not alter Na+,K+-ATPase activity in hippocampal homogenates but
decreases Na+,K+-ATPase activity when incubated with slices plus
homogenate. In addition, spermidine increases the NOx levels in
hippocampal slices and this effect was prevented by MK-801 and
arcaine.
It has been shown that the polycationic nature of polyamines
confers them the property of modifying the activity of many enzymes,
among them, the Na+,K+-ATPase (Charlton and Baylis, 1990; Heinrich-
Hirsch et al., 1977; Quarfoth et al., 1978; Tashima and Hasegawa, 1975;
Tashima et al., 1977, 1981). It has been previously argued thatFig. 7. Effect of co-incubation of spermidine (0.5 μM) and MK-801 (100 μM) (A) or
spermidine (0.5 μM) and arcaine (0.5 μM) (B) on NOx content of rat hippocampal
slices. Data are mean±S.E.M for n=7 in each group. *Indicates a signiﬁcant difference
compared with control group.polyamine positive charges may interact with the cationic-binding
domains of the Na+,K+-ATPase, classically described to be rich in acidic
amino acid residues in mammals (Johnson et al., 1995; Kuntzweiler et
al., 1995). Accordingly, the effect of polyamines increases with the
number of positive charges in the molecule (Heinrich-Hirsch et al.,
1977; Quarfoth et al., 1978). It has been described that polyamines
decrease the apparent afﬁnity of the Na+,K+-ATPase for Na+ in the
cytoplasmic site, blocking the formation of phosphoenzyme state
formation (E-P), which is Na+-dependent. The polyamines also
stabilize the Na+,K+-ATPase phosphorylated intermediate, limiting
the rate and the reaction cycle of this ATPase (Quarfoth et al., 1978; Silva
et al., 2008).
Experimental evidence supports that both spermidine and sper-
mine, in the mM range, inhibit Na+,K+-ATPase activity in rat brain
microsomal membranes by competing with the monovalent activating
cations involved in the ATPase reaction (Quarfoth et al., 1978). Other
studies performed with chick (Gallus domesticus) brain demonstrated
that 40 μM spermidine inhibited nearly 50% of the Na+,K+-ATPase
activity, while 100 μM spermidine caused an inhibition of 20%
(Heinrich-Hirsch et al., 1977). The same study has shown that
putrescine is devoid of effect. Heinrich-Hirsch et al. (1977) have
suggested that this effect of polyamines is due to a competitive
inhibition with cations, since increasing Na+, Mg2+ and ATP concen-
trations reverses the inhibition.
The currently described inhibitory effect of spermidine on Na+,K+-
ATPase activity was observed only in hippocampal slices, suggesting
that spermidine requires an intact cellular system. Alternatively, one
might argue that an intracellular component could block the inhibitory
effect of spermidine on Na+,K+-ATPase activity. We have investigated
this possibility by incubating slices with tissue homogenates and
spermidine. Due to the polycationic nature of polyamine, negatively
charged biomolecules present in the intracellular content could act as
possible chelators of polyamines. Co-incubation of the spermidine with
slices plus homogenized hippocampal slices does not prevent the
inhibitory effect of spermidine on the Na+,K+-ATPase activity in slices,
showing that intracellular components do not block the inhibitory
effect of spermidine.
Accumulating evidence suggests that polyamines dually modulate
the NMDA receptor (Rock and Macdonald, 1995; Williams, 1997b;
Williams et al., 1994). Polyamines enhance [3H]MK-801 and [3H]TCP
binding to the NMDA receptor at low micromolar concentrations but,
at high concentrations, do not alter the binding of these ligands
(Ransom and Stec, 1988; Sacaan and Johnson, 1990b; Williams,
1997a,b). Accordingly, while low concentrations of polyamine
spermidine enhance NMDA-evoked currents, high concentrations
produce less enhancement or inhibit such currents (Rock and
Macdonald, 1995; Sprosen and Woodruff, 1990; Williams, 1997b).
Considering that spermidine positively modulates NMDA receptor
conductance, we investigated whether the inhibitory effect of spermi-
dine on theNa+,K+-ATPase activity involvedNMDA receptor-mediated
mechanisms. MK-801, a non-competitive antagonist of the NMDA
receptor, and arcaine, an antagonist of the polyamine binding site at the
NMDA receptor, prevented the inhibitory effect of spermidine on Na+,
K+-ATPase activity induced by spermidine. This result suggests the
involvement of NMDA receptor in this effect. Since our ﬁndings support
the involvement of NMDA receptors in the inhibitory effect of
spermidine on Na+,K+-ATPase activity (Fig. 2), the inhibitory effect of
spermidine on Na+,K+-ATPase activity was also expected to be
biphasic. The ﬁndings shown in Fig. 1A support this view.
Previous studies have shown that NMDA decreases Na+,K+-
ATPase activity in rats and mice cerebellum granule cells, and that
this effect is attenuated by AP5 and MK-801, both antagonists of the
NMDA receptor (Boldyrev et al., 2003, 2004; Bulygina et al., 2002).
These data corroborate the results presented in this study, in which
the NMDA receptor activation decreased Na+,K+-ATPase activity.
Curiously, a signiﬁcant increase of free calcium concentration coupled
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from rat cerebral cortex and hippocampus after their exposure to
glutamate (Avrova et al., 1999; Tiurina et al., 1998). The presence of
L-NAME in the incubation medium prevented the increase of [Ca2+]i
induced by glutamate and the inactivation of Na+,K+-ATPase
(Avrova et al., 1999). These studies suggest the involvement of
NMDA receptors and nitric oxide synthase in glutamate-induced
decrease of Na+,K+-ATPase activity.
It is known thatNMDA receptor activation increases NO synthesis by
increasing NOS activity (Prast and Philippu, 2001; Sattler et al., 1999).
NO is a retrograde messenger which diffuses through the cellular
membranes and most of NO-mediated physiological processes are
thought to occur through the activation of guanylate cyclase and PKG
(East and Garthwaite, 1991). We found that L-NAME, a nitric oxide
synthase inhibitor, prevented the inhibitory effect of spermidine on the
Na+,K+-ATPase, indicating the involvement of NOS in this effect. These
results are also in agreement with those studies that have shown
that L-NAME prevents the decrease in Na+,K+-ATPase activity
induced by arginine (Delwing et al., 2008; Wyse et al., 2001), and
suggest that nitric oxide decreases Na+,K+-ATPase activity.
Furthermore, we show that spermidine increased levels of
nitrate and nitrite (NOx) when incubated with slices of hippocampus.
Co-incubation of spermidine with MK-801 and arcaine showed that
both prevent the increase of the content of NOx in slices. These results
show that spermidine increases the content of NOx and this effect
occurs through the activation of NMDA receptor. As observed in Fig. 6,
1 μM spermidine produced a less robust effect on NOx content than did
the 0.5 μM concentration. This is curious given that other data
demonstrate a greater effect of the 1 μM spermidine on Na+,K+-
ATPase activity. However, the ﬁrst point to be considered is that
statistical analysis of the data did not reveal a statistically signiﬁcant
difference between Na+,K+-ATPase activity of 0.5 and 1.0 μM
spermidine groups (Fig. 1A). Although 0.5 μM spermidine group
had a higher NOx content than 1.0 μM spermidine, it is possible that
both spermidine concentrations activate NMDA receptor/NOS/
cGMP/PKG in the same way at the end of the cascade. Because the
Na+,K+-ATPase is more distal (in terms of sequence of consecutiveFig. 8. NMDA receptor/NOS/cGMP/PKG pathway decreases Na+,K+-ATPase activity. Sperm
(100 μM), arcaine (0.5 μM), L-NAME (100 μM), ODQ (10 μM), KT5823 (2 μM) prevented the
which PKG decreases Na+,K+-ATPase activity are not determined.biochemical events of the signaling cascade) than the synthesis of
NOx, it is possible that the ampliﬁcation of signal provided by the
cascade maintained the effect on PKG. This occurs because the
further down the stimulus–response pathway the effect is observed,
the more ampliﬁed the signal (the better the efﬁcacy). Alternatively,
it is possible that counter-regulatory mechanisms, also triggered by
NO, may be involved in this effect.
In line with this view, given the involvement of NOS and NO in
inhibitory effect of spermidine on the Na+,K+-ATPase, we investi-
gated whether guanylate cyclase and PKG are involved in this effect.
ODQ, a guanylate cyclase inhibitor, and KT5823, a PKG inhibitor,
prevented the inhibitory effect provided by spermidine, further
supporting the role of cGMP/PKG pathway in the currently described
decrease of Na+,K+-ATPase activity by spermidine.
Fotis et al. (1999) have shown that PKG phosphorylates Na+,K+-
ATPase, and by this means decreases activity in mammalian kidney
cells and Xenopus oocytes. Although there is evidence that PKG
directly phosphorylates the alpha subunit of the enzyme in oocytes,
the target amino acid residues are currently unknown. Moreover, it is
not known whether brain Na+,K+-ATPase is phosphorylated by PKG.
Therefore, it is also possible that indirect mechanisms, unrelated to
direct PKG-mediated phosphorylation of the pump modulated Na+,
K+-ATPase. In fact, there is evidence supporting that nNOS-derived
NO activates extracellular signal-regulated kinase (ERK) (Gallo and
Iadecola, 2011). Since ERK pathway can modulate Na+,K+-ATPase
activity depending on the tissue and animal used (Al-Khalili et al.,
2004; Khundmiri et al., 2008; Krasnikova, 1991; Zhong et al., 2004),
one might speculate its involvement in the currently reported effect
of spermidine. In addition, signaling pathway cGMP/PKG might
activate protein phosphatase-1 which has been described to increase
the activity of Na+,K+-ATPase in rat cerebellar slices, probably
because sodium pump dephosphorylation accelerates enzyme cata-
lytic cycle (Kawamoto et al., 2008). Therefore, further studies are
necessary to clarify this point.
Considering that spermidine concentrations are approximately
0.5 μmol per gram of tissue in the hippocampus (Anderson et al.,
1975; Seiler and Schmidt-Glenewinkel, 1975), and that the spermidineidine, by activating NMDA receptor increases NOS activity and NO synthesis. MK-801
inhibitory effect of spermidine on Na+,K+-ATPase activity. The exact mechanisms by
85F.B. Carvalho et al. / European Journal of Pharmacology 684 (2012) 79–86concentrations that decreased Na+,K+-ATPase activity described
herein are in the low micromolar range, it is possible that physiolog-
ically released spermidine decreases Na+,K+-ATPase activity in neural
tissue. While it is not possible to determine whether glial or neuronal
Na+,K+-ATPases are preferentially affected by spermidine, it is
conceivable that polyamines may alter both cell types. If this were the
case, spermidine could alter sodium and potassium plasma mem-
brane gradients, potentially facilitating neuronal depolarization and
impairing sodium and potassium gradient-dependent transport
processes, such as neurotransmitter uptake, ultimately facilitating
neurotransmission (Benarroch, 2011; Gether et al., 2006; Gouaux,
2009). This is in agreement with the ﬁndings that injection of minute
amounts (0.02–2 nmol) of spermidine into the hippocampus or
amygdala improves, while doses above 20 nmol/structure have no
effect on the memory of rats (Rubin et al., 2000, 2004). On the other
hand, excessive spermidine production and/or release due to
pathological causes could have minimal effect on Na+,K+-ATPase,
and maintain sodium and potassium gradient-dependent processes.
In addition, the concentrations of polyamines in speciﬁc compart-
ments, such as vesicles and synaptic cleft, are not known. It is very
possible that the concentrations used in our study have a physio-
logical relevance, since it has been shown that spermidine
(3–100 μM) enhances [3H]MK-801 binding (Ransom and Stec,
1988; Reynolds and Miller, 1989; Sacaan and Johnson, 1990a) with
EC50 of 20.1 μM (Bakker et al., 1991).
While the exact mechanisms by which spermidine decreases Na+,
K+-ATPase activity are not determined, the current study presents
convincing evidence supporting a role for NMDA receptor/NOS/
cGMP/PKG pathway in this effect. The currently reported modulation
of Na+,K+-ATPase activity suggests this enzyme as a NMDA receptor
target that may underlie some effects of glutamate. In this study (see
Fig. 8), spermidine inhibits activity of Na+,K+-ATPase in slices of rat
hippocampus via NMDA receptor and MK-801, arcaine, L-NAME, ODQ
and KT5823 prevent this effect, suggesting that NMDA receptor/NO/
cGMP/PKG mechanisms are involved in the effect of spermidine on
Na+,K+-ATPase activity.
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